Showing 1251-1260 of 2942 results for "".
Small Fiber Neuropathy
https://practicalneurology.com/diseases-diagnoses/headache-pain/small-fiber-neuropathy/31811/Small fiber neuropathy has a benign course but can affect quality of life; individualize treatment to control underlying causes and alleviate pain.Rational Polypharmacy for Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/rational-polypharmacy-for-migraine/31898/Polypharmacy can be effective for migraine refractory to monotherapy.Susac Syndrome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/susac-syndrome/31619/A triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss.Inpatient Rehabilitation Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/inpatient-rehabilitation-following-traumatic-brain-injury/31989/Unique care and benefits of inpatient rehabilitation facilities compared with other care settingsChronic Effects of Traumatic Brain Injury in Military Service Members
https://practicalneurology.com/diseases-diagnoses/tbi/chronic-effects-of-traumatic-brain-injury-in-military-service-members/31992/TBI-associated symptoms in military service members, including PTSD, CTE, and long-term health effectsHyperglycemia Management
https://practicalneurology.com/diseases-diagnoses/stroke/hyperglycemia-management/31861/The role of hyperglycemia management after ischemic stroke remains elusive.Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Poststroke Rehabilitation Care
https://practicalneurology.com/diseases-diagnoses/stroke/poststroke-rehabilitation-care/31864/Best-practices in poststroke rehabilitation from team-based care to prognostication.COVID-19, Vaccinations & Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/covid-19-vaccinations-multiple-sclerosis/31876/Multiple sclerosis and its disease-modifying treatments affect risks of COVID-19 and response to COVID-19 vaccination.